Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
|ClinicalTrials.gov Identifier: NCT01477671|
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : January 11, 2018
This is a descriptive prospective community-based seroprevalence study.
- To determine the prevalence of specific antibodies (immunoglobulin G [IgG]) against dengue in healthy 5 to 10 year-old children in India.
- To determine the dengue virus serotype (DeNV-1,2,3 and /or 4) specific to the antibodies in positive (IgG) samples
- To estimate the prevalence of specific antibodies (IgG) against Japanese encephalitis in healthy 5 to 10 year-old children in India.
|Condition or disease|
|Dengue Dengue Fever Dengue Hemorrhagic Fever|
|Study Type :||Observational|
|Actual Enrollment :||667 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||September 2012|
|Actual Study Completion Date :||December 2013|
Participants aged between 5 and 10 year-old on day of inclusion.
- Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4 [ Time Frame: Baseline ]
- Prevalence of positive serum samples with JEV specific IgG antibodies [ Time Frame: Baseline ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01477671
|Kalyani, West Bengali, India, 741235|
|Bangalore, India, 560070|
|Hyderabad, India, 500063|
|New Delhi, India, 110002|
|Study Director:||Medical Director||Sanofi Pasteur SA|